Bank of Montreal
TBPH icon

Bank of Montreal’s Theravance Biopharma TBPH Stock Holding History

Bank of Montreal’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-160,138
Closed -$1.41M – 4227
2024
Q2 		$1.41M Buy
160,138
+93,702
+141% +$846K ﹤0.01% 1838
2024
Q1 		$599K Buy
+66,436
New +$616K ﹤0.01% 2326
2022
Q4 		– Sell
-205,680
Closed -$2.1K – 4270
2022
Q3 		$2.1K Sell
205,680
-11,847
-5% -$111K ﹤0.01% 1785
2022
Q2 		$1.95K Buy
+217,527
New +$2M ﹤0.01% 1900
2021
Q2 		– Sell
-1,603
Closed -$35K – 4832
2021
Q1 		$35K Sell
1,603
-5,980
-79% -$114K ﹤0.01% 3851
2020
Q4 		$127K Buy
7,583
+4,787
+171% +$85.9K ﹤0.01% 3463
2020
Q3 		$42K Sell
2,796
-1,718
-38% -$32.2K ﹤0.01% 3512
2020
Q2 		$97K Buy
4,514
+3,672
+436% +$94.3K ﹤0.01% 3108
2020
Q1 		$19K Sell
842
-5,654
-87% -$142K ﹤0.01% 3276
2019
Q4 		$168K Buy
6,496
+1,527
+31% +$29.7K ﹤0.01% 3256
2019
Q3 		$97K Sell
4,969
-98,887
-95% -$2M ﹤0.01% 3320
2019
Q2 		$1.7M Buy
103,856
+103,490
+28,276% +$2.1M ﹤0.01% 1790
2019
Q1 		$8K Sell
366
-533
-59% -$13.5K ﹤0.01% 3942
2018
Q4 		$23K Buy
899
+314
+54% +$8.48K ﹤0.01% 3601
2018
Q3 		$19K Sell
585
-7
-1% -$191 ﹤0.01% 3730
2018
Q2 		$14K Sell
592
-5,618
-90% -$133K ﹤0.01% 3865
2018
Q1 		$151K Buy
6,210
+5,517
+796% +$152K ﹤0.01% 2767
2017
Q4 		$19K Buy
693
+108
+18% +$3.2K ﹤0.01% 3612
2017
Q3 		$20K Hold
585
– – ﹤0.01% 3520
2017
Q2 		$23K Hold
585
– – ﹤0.01% 3488
2017
Q1 		$22K Hold
585
– – ﹤0.01% 3343
2016
Q4 		$16K Buy
585
+320
+121% +$9.93K ﹤0.01% 3463
2016
Q3 		$10K Buy
265
+85
+47% +$2.37K ﹤0.01% 3560
2016
Q2 		$4K Sell
180
-133
-42% -$2.87K ﹤0.01% 3800
2016
Q1 		$6K Hold
313
– – ﹤0.01% 3750
2015
Q4 		$5K Buy
313
+180
+135% +$2.86K ﹤0.01% 3802
2015
Q3 		$1K Hold
133
– – ﹤0.01% 3893
2015
Q2 		$2K Hold
133
– – ﹤0.01% 3769
2015
Q1 		$2K Hold
133
– – ﹤0.01% 3799
2014
Q4 		$2K Buy
+133
New +$2.32K ﹤0.01% 3848

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of Montreal's TBPH Position: Q3 2024 in Review

Bank of Montreal sold out of Theravance Biopharma (TBPH) in Q3 2024, closing a stake of 160,138 shares — an estimated $1.41M sold.

Bank of Montreal first reported a position in TBPH in Q4 2014 and held it in 30 quarters. The position peaked at $1.7M in Q2 2019. 119 funds tracked by Wall St. Rank hold TBPH as of Q3 2024.

  • Bank of Montreal reported no remaining Theravance Biopharma position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 160,138 Theravance Biopharma shares in Q3 2024, an estimated $1.41M.
  • Bank of Montreal first reported a position in Theravance Biopharma in Q4 2014 and held it in 30 quarters.
  • Bank of Montreal's Theravance Biopharma position peaked at $1.7M in Q2 2019.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.